Ocugen (OCGN) Total Current Liabilities (2014 - 2026)
Ocugen's (OCGN) quarterly Total Current Liabilities came in at $20.7 million in Q1 2026, up 22.63% YoY from $16.9 million in Q1 2025, and down 10.13% on a QoQ basis from $23.0 million in Q4 2025.
Ocugen (OCGN) Total Current Liabilities (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 13 years of Total Current Liabilities data on file, last reported at $20.7 million in Q1 2026.
- Quarterly Total Current Liabilities rose 22.63% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.7 million (up 22.63% YoY) and the FY2025 annual result came in at $23.0 million, up 6.74% from the prior year.
- Total Current Liabilities declined to $20.7 million in Q1 2026, from $23.0 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $28.5 million in Q4 2022 to a low of $13.3 million in Q1 2022.
- A 5-year average of $20.2 million and a median of $19.7 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 307.59% — and 2023, when it slumped 40.1%.
- Tracing OCGN's Total Current Liabilities over 5 years: stood at $28.5 million in 2022, then tumbled by 40.1% to $17.1 million in 2023, then gained by 26.33% to $21.6 million in 2024, then grew by 6.74% to $23.0 million in 2025, then declined by 10.13% to $20.7 million in 2026.
- The last three Total Current Liabilities figures came in at $20.7 million (Q1 2026), $23.0 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Ocugen | 457.71 Mn | 357.61 Mn | - | 133.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 133.08 Mn |
| Mar 31, 2026 | 20.71 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 20.36 Mn |
| Jun 30, 2025 | 17.99 Mn |
| Mar 31, 2025 | 16.89 Mn |
| Dec 31, 2024 | 21.59 Mn |
| Sep 30, 2024 | 15.76 Mn |
| Jun 30, 2024 | 17.97 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 17.09 Mn |
| Sep 30, 2023 | 19.73 Mn |
| Jun 30, 2023 | 24.50 Mn |
| Mar 31, 2023 | 26.58 Mn |
| Dec 31, 2022 | 28.53 Mn |
| Sep 30, 2022 | 24.52 Mn |
| Jun 30, 2022 | 17.96 Mn |
| Mar 31, 2022 | 13.30 Mn |
| Dec 31, 2021 | 7.00 Mn |
| Sep 30, 2021 | 6.23 Mn |